Gros L - Search Results

1

Long-lasting protective antiviral immunity induced by passive immunotherapies requires both neutralizing and effector functions of the administered monoclonal antibody.

Nasser R, Pelegrin M, Michaud HA, Plays M, Piechaczyk M, Gros L. Nasser R, et al. Among authors: gros l. J Virol. 2010 Oct;84(19):10169-81. doi: 10.1128/JVI.00568-10. Epub 2010 Jul 7. J Virol. 2010. PMID: 20610721 Free PMC article.

2

Monoclonal antibody 667 recognizes the variable region A motif of the ecotropic retrovirus CasBrE envelope glycoprotein and inhibits Env binding to the viral receptor.

Dreja H, Gros L, Villard S, Bachrach E, Oates A, Granier C, Chardes T, Mani JC, Piechaczyk M, Pelegrin M. Dreja H, et al. Among authors: gros l. J Virol. 2003 Oct;77(20):10984-93. doi: 10.1128/jvi.77.20.10984-10993.2003. J Virol. 2003. PMID: 14512547 Free PMC article.

3

Monoclonal antibody-based genetic immunotherapy.

Pelegrin M, Gros L, Dreja H, Piechaczyk M. Pelegrin M, et al. Among authors: gros l. Curr Gene Ther. 2004 Sep;4(3):347-56. doi: 10.2174/1566523043346246. Curr Gene Ther. 2004. PMID: 15384948 Review.

4

Induction of long-term protective antiviral endogenous immune response by short neutralizing monoclonal antibody treatment.

Gros L, Dreja H, Fiser AL, Plays M, Pelegrin M, Piechaczyk M. Gros L, et al. J Virol. 2005 May;79(10):6272-80. doi: 10.1128/JVI.79.10.6272-6280.2005. J Virol. 2005. PMID: 15858011 Free PMC article.

5

Efficient mother-to-child transfer of antiretroviral immunity in the context of preclinical monoclonal antibody-based immunotherapy.

Gros L, Pelegrin M, Plays M, Piechaczyk M. Gros L, et al. J Virol. 2006 Oct;80(20):10191-200. doi: 10.1128/JVI.01095-06. J Virol. 2006. PMID: 17005696 Free PMC article.

6

Endogenous cytotoxic T-cell response contributes to the long-term antiretroviral protection induced by a short period of antibody-based immunotherapy of neonatally infected mice.

Gros L, Pelegrin M, Michaud HA, Bianco S, Hernandez J, Jacquet C, Piechaczyk M. Gros L, et al. J Virol. 2008 Feb;82(3):1339-49. doi: 10.1128/JVI.01970-07. Epub 2007 Nov 21. J Virol. 2008. PMID: 18032505 Free PMC article.

7

A crucial role for infected-cell/antibody immune complexes in the enhancement of endogenous antiviral immunity by short passive immunotherapy.

Michaud HA, Gomard T, Gros L, Thiolon K, Nasser R, Jacquet C, Hernandez J, Piechaczyk M, Pelegrin M. Michaud HA, et al. Among authors: gros l. PLoS Pathog. 2010 Jun 10;6(6):e1000948. doi: 10.1371/journal.ppat.1000948. PLoS Pathog. 2010. PMID: 20548955 Free PMC article.

8

Control of regulatory T cells is necessary for vaccine-like effects of antiviral immunotherapy by monoclonal antibodies.

Nasser R, Pelegrin M, Plays M, Gros L, Piechaczyk M. Nasser R, et al. Among authors: gros l. Blood. 2013 Feb 14;121(7):1102-11. doi: 10.1182/blood-2012-06-432153. Epub 2012 Dec 20. Blood. 2013. PMID: 23264590 Free article.

9

[Vaccine-like effects of antiviral monoclonal antibodies: a novel therapeutic perspective?].

Pelegrin M, Gros L, Piechaczyk M. Pelegrin M, et al. Among authors: gros l. Med Sci (Paris). 2013 May;29(5):457-60. doi: 10.1051/medsci/2013295005. Epub 2013 May 28. Med Sci (Paris). 2013. PMID: 23732091 Free article. French. No abstract available.

10

Tumor antigen-targeting monoclonal antibody-based immunotherapy: Orchestrating combined strategies for the development of long-term antitumor immunity.

Michaud HA, Eliaou JF, Lafont V, Bonnefoy N, Gros L. Michaud HA, et al. Among authors: gros l. Oncoimmunology. 2014 Dec 13;3(9):e955684. doi: 10.4161/21624011.2014.955684. eCollection 2014 Oct. Oncoimmunology. 2014. PMID: 25941618 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters